CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: fludrocortisone
Accession: CHEBI:50885
browse the term
Definition: A mineralocorticoid that has formula C21H29FO5.
Synonyms: exact_synonym: 9-fluoro-11beta,17,21-trihydroxypregn-4-ene-3,20-dione
related_synonym: 9ALPHA-FLUOROCORTISOL; Formula=C21H29FO5; InChI=1S/C21H29FO5/c1-18-7-5-13(24)9-12(18)3-4-15-14-6-8-20(27,17(26)11-23)19(14,2)10-16(25)21(15,18)22/h9,14-16,23,25,27H,3-8,10-11H2,1-2H3/t14-,15-,16-,18-,19-,20-,21-/m0/s1; InChIKey=AAXVEMMRQDVLJB-BULBTXNYSA-N; SMILES=[H][C@@]12CC[C@](O)(C(=O)CO)[C@@]1(C)C[C@H](O)[C@@]1(F)[C@@]2([H])CCC2=CC(=O)CC[C@]12C; fludrocortisona; fludrocortisonum
alt_id: CHEBI:46556; CHEBI:5101
xref: Beilstein:3014278; CAS:127-31-1; DrugBank:DB00687; KEGG:C07004; KEGG:D07967; LIPID_MAPS_instance:LMST02030103
xref_mesh: MESH:D005438
xref: PDBeChem:ZK5; Patent:GB792224; Patent:US2852511; Wikipedia:Fludrocortisone
G
Ar
androgen receptor
multiple interactions
ISO
bicalutamide inhibits the reaction [Fludrocortisone results in increased activity of AR protein mutant form]; Fludrocortisone binds to and results in increased activity of AR protein mutant form; Mifepristone inhibits the reaction [Fludrocortisone results in increased activity of AR protein mutant form]
CTD
PMID:11956172
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
G
Bmp6
bone morphogenetic protein 6
decreases expression
ISO
Fludrocortisone results in decreased expression of BMP6 mRNA
CTD
PMID:32816093
NCBI chr17:26,318,121...26,469,691
Ensembl chr17:26,318,569...26,470,365
G
Ccl2
C-C motif chemokine ligand 2
decreases expression
ISO
Fludrocortisone results in decreased expression of CCL2 protein
CTD
PMID:20116850
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
G
Ccl3
C-C motif chemokine ligand 3
increases expression
ISO
Fludrocortisone results in increased expression of CCL3 protein
CTD
PMID:20116850
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
increases expression
ISO
Fludrocortisone results in increased expression of CCL4 protein
CTD
PMID:20116850
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ereg
epiregulin
decreases expression
ISO
Fludrocortisone results in decreased expression of EREG mRNA
CTD
PMID:32816093
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
G
Il1a
interleukin 1 alpha
decreases expression
ISO
Fludrocortisone results in decreased expression of IL1A mRNA
CTD
PMID:32816093
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
G
Il1b
interleukin 1 beta
decreases expression
ISO
Fludrocortisone results in decreased expression of IL1B mRNA
CTD
PMID:32816093
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Klk1c10
kallikrein 1-related peptidase C10
increases expression
ISO
Fludrocortisone results in increased expression of KLK3 protein
CTD
PMID:11956172
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
G
Met
MET proto-oncogene, receptor tyrosine kinase
increases expression
ISO
Fludrocortisone results in increased expression of MET mRNA
CTD
PMID:32816093
NCBI chr 4:45,790,456...45,898,139
Ensembl chr 4:45,790,791...45,897,876
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
multiple interactions
ISO
Fludrocortisone binds to and results in increased activity of NR3C1 protein
CTD
PMID:11956172
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
G
Nr3c2
nuclear receptor subfamily 3, group C, member 2
multiple interactions
ISO
[Fludrocortisone binds to and results in increased activity of NR3C2 protein] which results in decreased abundance of Hydrocortisone; [Fludrocortisone binds to and results in increased activity of NR3C2 protein] which results in decreased expression of POMC protein
CTD
PMID:16566900
NCBI chr19:30,715,634...31,059,885
Ensembl chr19:30,715,648...31,059,885
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression
ISO
Fludrocortisone results in increased expression of PID1 mRNA
CTD
PMID:32816093
NCBI chr 9:85,284,335...85,503,035
Ensembl chr 9:85,284,335...85,503,044
G
Pomc
proopiomelanocortin
multiple interactions
ISO
[Fludrocortisone binds to and results in increased activity of NR3C2 protein] which results in decreased expression of POMC protein
CTD
PMID:16566900
NCBI chr 6:26,939,844...26,945,666
Ensembl chr 6:26,939,837...26,945,664
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
Fludrocortisone results in decreased expression of PTGS2 mRNA
CTD
PMID:32816093
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Slc7a11
solute carrier family 7 member 11
decreases expression
ISO
Fludrocortisone results in decreased expression of SLC7A11 mRNA
CTD
PMID:32816093
NCBI chr 2:134,382,002...134,517,622
Ensembl chr 2:133,963,107...134,517,536
G
Slpi
secretory leukocyte peptidase inhibitor
increases expression
ISO
Fludrocortisone results in increased expression of SLPI mRNA
CTD
PMID:32816093
NCBI chr 3:153,082,208...153,084,457
Ensembl chr 3:153,082,369...153,084,453
G
Tnfaip6
TNF alpha induced protein 6
decreases expression
ISO
Fludrocortisone results in decreased expression of TNFAIP6 mRNA
CTD
PMID:32816093
NCBI chr 3:36,502,250...36,521,652
Ensembl chr 3:36,502,188...36,521,649
G
Vegfa
vascular endothelial growth factor A
decreases expression
ISO
Fludrocortisone results in decreased expression of VEGFA protein
CTD
PMID:20116850
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all